Impact Health is a mission-driven health policy and strategic consulting firm dedicated to improving health and well-being for all.
OUR SERVICES
Strategic Planning
Integrate mission-aligned policy expertise and political acumen into planning and executing your goals.
Government Contracting
Track record of success supporting states and municipalities in innovating or launching new programs.
Our proprietary method for tracking, aggregating, and analyzing state policy trends.
If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Office of Civil Rights Issues Guidance on Patient Confidentiality of Substance Use Disorder Records for Demonstrating an Exclusion from Medicaid Work Requirements
The U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) recently issued guidance for state Medicaid programs that clarifies when the regulation establishing Confidentiality of Substance Use Disorder (SUD) Patient Records under 42 CFR part 2 (“Part 2”) would allow an agency to use protected SUD patient records to verify an exclusion from Medicaid work requirements…. (Marceno, October 2, 2026) #Insurance Coverage, #Mental and Behavioral Health, #Public Health
Approved 340B Rebate Model Pilot Program Manufacturer Plans Released
The Health Resources and Services Administration (HRSA) updated the 340B Rebate Model Pilot Program webpage to reflect the ten approved manufacturer plans, which include information on each manufacturer’s approach to rebates, technology platforms being utilized, reporting requirements, and data. The model is limited to the participating manufacturers’ drugs that are selected drugs under the Medicare Drug Price Negotiation Program for… (Slifer, October 1, 2026) #340B, #Prescription Drugs



